SCHEMBL10411370

SCHEMBL10411370

O=C(Nc1ccc(CCc2ccc3ccccc3c2)cc1)C1=C(O)c2ccccc2SC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 3/20 0.45
▸ MAPT P10636 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ NR1H4 Q96RI1 2/20 0.41
▸ PTGES O14684 1/20 0.41
▸ HCAR2 Q8TDS4 1/20 0.40
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ DEGS1 O15121 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ PLG P00747 2/20 0.39
▸ KLK1 P06870 2/20 0.39
▸ KLK6 Q92876 2/20 0.39
▸ FFAR1 O14842 1/20 0.39
▸ NLRP3 Q96P20 1/20 0.39
▸ TRPC3 Q13507 1/20 0.39
▸ TRPC7 Q9HCX4 1/20 0.39
▸ TRPC5 Q9UL62 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412130 0.88 ALOX15 (0.56) ALOX15MAPTTP53PTGES
SCHEMBL10412491 0.85 NAMPT (0.41) MAPTTP53NPC1RAB9AKMT2A
SCHEMBL10412947 0.84 MAPT (0.50) MAPTTP53PTGESNPC1RAB9A
SCHEMBL10413084 0.83 MAPT (0.39) ALOX15MAPTTP53PTGESKMT2A
SCHEMBL10412528 0.83 S1PR1 (0.45) MAPTKMT2AMEN1FFAR1
SCHEMBL10411974 0.83 MAPT (0.43) ALOX15MAPTTP53POLB
SCHEMBL10411377 0.82 PTGES (0.52) ALOX15MAPTTP53PTGESNPC1
SCHEMBL10412040 0.82 MAPT (0.45) ALOX15MAPTTP53PTGESHCAR2
SCHEMBL10412487 0.80 ALOX15 (0.48) ALOX15MAPTTP53
SCHEMBL10412940 0.80 POLB (0.45) MAPTTP53NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US claimed
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US disclosed
US-4874758-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-10-17 — — US disclosed
US-4868195-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868200-A LEUKOTRIENES, LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868205-A ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868199-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US disclosed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
Send feedback